An Errant Editing Enzyme Promotes Tumor Suppressor Loss and Leukemia Propagation
Health & BehaviorUC San Diego researchers have found a stem cell enzyme copy edits more than 20 tumor types, providing new therapeutic target for preventing cancer cell resistance to chemotherapy and radiation.